{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T03:16:39Z","timestamp":1782184599406,"version":"3.54.5"},"reference-count":123,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,8]],"date-time":"2020-09-08T00:00:00Z","timestamp":1599523200000},"content-version":"vor","delay-in-days":1103,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jlr.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Lipid Research"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1194\/jlr.s074039","type":"journal-article","created":{"date-parts":[[2017,7,13]],"date-time":"2017-07-13T00:50:23Z","timestamp":1499907023000},"page":"1765-1776","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Knowns and unknowns in the care of pediatric familial hypercholesterolemia"],"prefix":"10.1016","volume":"58","author":[{"given":"Andrew C.","family":"Martin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel S.","family":"Gidding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Wiegman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald F.","family":"Watts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1194\/jlr.S074039_bib1","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jpeds.2015.11.019","article-title":"Prevalence of familial hypercholesterolemia in adolescents: potential value of universal screening?","volume":"170","author":"Pang","year":"2016","journal-title":"J. Pediatr."},{"key":"10.1194\/jlr.S074039_bib2","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.1210\/jc.2012-1563","article-title":"Familial hypercholesterolemia in the Danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication","volume":"97","author":"Benn","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1194\/jlr.S074039_bib3","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ijcard.2015.03.027","article-title":"Prevalence and treatment of familial hypercholesterolaemia in Australian communities","volume":"185","author":"Watts","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"10.1194\/jlr.S074039_bib4","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/eurheartj\/ehu058","article-title":"Homozygous autosomal dominant hypercholesterolaemia in the Netherlands: prevalence, genotype-phenotype relationship, and clinical outcome","volume":"36","author":"Sjouke","year":"2015","journal-title":"Eur. Heart J."},{"key":"10.1194\/jlr.S074039_bib5","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1056\/NEJMoa1602777","article-title":"Child-parent familial hypercholesterolemia screening in primary care","volume":"375","author":"Wald","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1194\/jlr.S074039_bib6","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1016\/j.jacc.2016.03.520","article-title":"Diagnostic yield and clinical utility of sequencing familial hypercholesterolemia genes in patients with severe hypercholesterolemia","volume":"67","author":"Khera","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1194\/jlr.S074039_bib7","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1177\/2047487314533218","article-title":"Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation","volume":"22","author":"Watts","year":"2015","journal-title":"Eur. J. Prev. Cardiol."},{"key":"10.1194\/jlr.S074039_bib8","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1161\/CIR.0000000000000297","article-title":"The agenda for familial hypercholesterolemia: a scientific statement from the American Heart Association","volume":"132","author":"Gidding","year":"2015","journal-title":"Circulation."},{"key":"10.1194\/jlr.S074039_bib9","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/S0140-6736(69)90930-1","article-title":"Risks of ischaemic heart-disease in familial hyperlipoproteinaemic states","volume":"2","author":"Slack","year":"1969","journal-title":"Lancet."},{"key":"10.1194\/jlr.S074039_bib10","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1161\/01.CIR.49.3.476","article-title":"Coronary artery disease in 116 kindred with familial type II hyperlipoproteinemia","volume":"49","author":"Stone","year":"1974","journal-title":"Circulation."},{"key":"10.1194\/jlr.S074039_bib11","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1161\/01.ATV.0000282193.31936.fd","article-title":"Intrauterine exposure to maternal atherosclerotic risk factors increases the susceptibility to atherosclerosis in adult life","volume":"27","author":"Alkemade","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1194\/jlr.S074039_bib12","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/S0140-6736(99)02131-5","article-title":"Influence of maternal hypercholesterolaemia during pregnancy on progression of early atherosclerotic lesions in childhood: fate of early lesions in children (FELIC) study","volume":"354","author":"Napoli","year":"1999","journal-title":"Lancet."},{"key":"10.1194\/jlr.S074039_bib13","doi-asserted-by":"crossref","first-page":"30T","DOI":"10.1016\/S0002-9149(98)00720-6","article-title":"Determinants of atherosclerosis in the young. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) research group","volume":"82","author":"McGill","year":"1998","journal-title":"Am. J. Cardiol."},{"key":"10.1194\/jlr.S074039_bib14","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1056\/NEJM198601163140302","article-title":"Relation of serum lipoprotein levels and systolic blood pressure to early atherosclerosis. The Bogalusa Heart Study","volume":"314","author":"Newman","year":"1986","journal-title":"N. Engl. J. Med."},{"key":"10.1194\/jlr.S074039_bib15","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.atherosclerosis.2014.05.917","article-title":"Markers of atherosclerotic development in children with familial hypercholesterolemia: a literature review","volume":"235","author":"Narverud","year":"2014","journal-title":"Atherosclerosis."},{"key":"10.1194\/jlr.S074039_bib16","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1365-2362.2006.01613.x","article-title":"Increased inflammatory markers in children with familial hypercholesterolaemia","volume":"36","author":"Ueland","year":"2006","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1194\/jlr.S074039_bib17","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0021-9150(02)00003-5","article-title":"Family history of cardiovascular events and endothelial dysfunction in children with familial hypercholesterolemia","volume":"163","author":"de Jongh","year":"2002","journal-title":"Atherosclerosis."},{"key":"10.1194\/jlr.S074039_bib18","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00246-013-0742-0","article-title":"Endothelial dysfunction, but not structural atherosclerosis, is evident early in children with heterozygous familial hypercholesterolemia","volume":"35","author":"Vlahos","year":"2014","journal-title":"Pediatr. Cardiol."},{"key":"10.1194\/jlr.S074039_bib19","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1365-2362.2010.02260.x","article-title":"Pulse wave velocity and augmentation index, but not intima-media thickness, are early indicators of vascular damage in hypercholesterolemic children","volume":"40","author":"Riggio","year":"2010","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1194\/jlr.S074039_bib20","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0140-6736(04)15467-6","article-title":"Arterial intima-media thickness in children heterozygous for familial hypercholesterolaemia","volume":"363","author":"Wiegman","year":"2004","journal-title":"Lancet."},{"key":"10.1194\/jlr.S074039_bib21","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1161\/CIRCRESAHA.114.301430","article-title":"Carotid intima-media thickness in children with familial hypercholesterolemia","volume":"114","author":"Kusters","year":"2014","journal-title":"Circ. Res."},{"key":"10.1194\/jlr.S074039_bib22","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1001\/jama.292.3.331","article-title":"Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial","volume":"292","author":"Wiegman","year":"2004","journal-title":"JAMA."},{"key":"10.1194\/jlr.S074039_bib23","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1001\/jama.2014.8892","article-title":"Ten-year follow-up after initiation of statin therapy in children with familial hypercholesterolemia","volume":"312","author":"Kusters","year":"2014","journal-title":"JAMA."},{"key":"10.1194\/jlr.S074039_bib24","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.116.025158","article-title":"Effect of rosuvastatin on carotid intima-media thickness in children with heterozygous familial hypercholesterolemia: The CHARON study","author":"Braamskamp","year":"2017","journal-title":"Circulation."},{"key":"10.1194\/jlr.S074039_bib25","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1093\/eurheartj\/ehv157","article-title":"Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment","volume":"36","author":"Wiegman","year":"2015","journal-title":"Eur. Heart J."},{"key":"10.1194\/jlr.S074039_bib26","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/MOL.0000000000000247","article-title":"Mendelian randomization studies: using naturally randomized genetic data to fill evidence gaps","volume":"26","author":"Ference","year":"2015","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1194\/jlr.S074039_bib27","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1093\/eurheartj\/eht273","article-title":"Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society","volume":"34","author":"Nordestgaard","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1194\/jlr.S074039_bib28","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jacl.2014.01.002","article-title":"Integrated guidance on the care of familial hypercholesterolemia from the International FH Foundation","volume":"8","author":"Watts","year":"2014","journal-title":"J. Clin. Lipidol."},{"key":"10.1194\/jlr.S074039_bib29","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jacl.2011.03.001","article-title":"Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia","volume":"5","author":"Goldberg","year":"2011","journal-title":"J. Clin. Lipidol."},{"key":"10.1194\/jlr.S074039_bib30","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.atherosclerosissup.2011.06.001","article-title":"Familial hypercholesterolaemia: a model of care for Australasia","volume":"12","author":"Watts","year":"2011","journal-title":"Atheroscler. Suppl."},{"key":"10.1194\/jlr.S074039_bib31","doi-asserted-by":"crossref","first-page":"E263","DOI":"10.1111\/jpc.12036","article-title":"Familial hypercholesterolaemia in children and adolescents: a new paediatric model of care","volume":"49","author":"Martin","year":"2013","journal-title":"J. Paediatr. Child Health."},{"key":"10.1194\/jlr.S074039_bib32","unstructured":"National Institute for Health and Clinical Excellence and the National Collaborating Centre for Primary Care. NICE clinical guideline 71. Identification and management of familial hypercholesterolaemia. Accessed June 25 2017, at www.nice.org.uk\/nicemedia\/pdf\/CG071NICEGuideline.pdf."},{"key":"10.1194\/jlr.S074039_bib33","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.atherosclerosis.2011.06.016","article-title":"Management of familial hypercholesterolemia in children and young adults: consensus paper developed by a panel of lipidologists, cardiologists, paediatricians, nutritionists, gastroenterologists, general practitioners and a patient organization","volume":"218","author":"Descamps","year":"2011","journal-title":"Atherosclerosis."},{"key":"10.1194\/jlr.S074039_bib34","series-title":"Principles and Practice of Screening for Disease","author":"Wilson","year":"1968"},{"key":"10.1194\/jlr.S074039_bib35","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/ajmg.a.34368","article-title":"The evaluation of cascade testing for familial hypercholesterolemia","volume":"158A","author":"Morris","year":"2012","journal-title":"Am. J. Med. Genet. A."},{"key":"10.1194\/jlr.S074039_bib36","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.atherosclerosis.2017.03.007","article-title":"Screening for familial hypercholesterolaemia in childhood: Avon Longitudinal Study of Parents and Children (ALSPAC)","volume":"260","author":"Futema","year":"2017","journal-title":"Atherosclerosis."},{"key":"10.1194\/jlr.S074039_bib37","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1136\/bmj.39300.616076.55","article-title":"Child-parent screening for familial hypercholesterolaemia: screening strategy based on a meta-analysis","volume":"335","author":"Wald","year":"2007","journal-title":"BMJ."},{"key":"10.1194\/jlr.S074039_bib38","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.jpeds.2011.06.006","article-title":"Child-parent screening for familial hypercholesterolemia","volume":"159","author":"Wald","year":"2011","journal-title":"J. Pediatr."},{"key":"10.1194\/jlr.S074039_bib39","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jpeds.2013.10.027","article-title":"Implementation of lipid screening guidelines in children by primary pediatric providers","volume":"164","author":"Dixon","year":"2014","journal-title":"J. Pediatr."},{"key":"10.1194\/jlr.S074039_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2016.12.078","article-title":"Cholesterol screening and treatment practices and preferences: a survey of United States pediatricians","author":"de Ferranti","year":"2017","journal-title":"J. Pediatr."},{"key":"10.1194\/jlr.S074039_bib41","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.jacc.2015.07.017","article-title":"Universal screening for familial hypercholesterolemia in children","volume":"66","author":"Klan\u010dar","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1194\/jlr.S074039_bib42","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0140-6736(12)62127-8","article-title":"Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a case-control study","volume":"381","author":"Talmud","year":"2013","journal-title":"Lancet."},{"key":"10.1194\/jlr.S074039_bib43","unstructured":"Lister, K., C. Molster, A. C. Martin, F. Bowman, A. Buaskis, A. Cho, A. Vickery, J. Garton-Smith, A. Kirke, and G. F. Watts, 2017. Screening for familial hypercholestrolaemia: engaging the public in policy direction (Abstract in 15th World Congress on Public Health. Melbourne, Australia, April 3\u20137, 2017)."},{"key":"10.1194\/jlr.S074039_bib44","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.atherosclerosis.2014.12.036","article-title":"Effectiveness of genetic cascade screening for familial hypercholesterolaemia using a centrally co-ordinated clinical service: an Australian experience","volume":"239","author":"Bell","year":"2015","journal-title":"Atherosclerosis."},{"key":"10.1194\/jlr.S074039_bib45","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1055\/s-2004-822992","article-title":"Cost-effectiveness analysis of the genetic screening program for familial hypercholesterolemia in The Netherlands","volume":"4","author":"Wonderling","year":"2004","journal-title":"Semin. Vasc. Med."},{"key":"10.1194\/jlr.S074039_bib46","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0140-6736(00)03587-X","article-title":"Review of first 5 years of screening for familial hypercholesterolaemia in the Netherlands","volume":"357","author":"Umans-Eckenhausen","year":"2001","journal-title":"Lancet."},{"key":"10.1194\/jlr.S074039_bib47","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1136\/bmj.324.7349.1303","article-title":"Cost effectiveness analysis of different approaches of screening for familial hypercholesterolaemia","volume":"324","author":"Marks","year":"2002","journal-title":"BMJ."},{"key":"10.1194\/jlr.S074039_bib48","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jacl.2014.05.008","article-title":"Cascade screen\u00ading based on genetic testing is cost-effective: evidence for the implementation of models of care for familial hypercholes\u00adterolemia","volume":"8","author":"Ademi","year":"2014","journal-title":"J. Clin. Lipidol."},{"key":"10.1194\/jlr.S074039_bib49","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1016\/j.ijcard.2013.01.280","article-title":"A systematic review of economic evaluations of the detection and treatment of familial hypercholesterolemia","volume":"167","author":"Ademi","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1194\/jlr.S074039_bib50","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/MOL.0000000000000365","article-title":"Challenges in the health economics of familial hypercholesterolemia","volume":"27","author":"Norman","year":"2016","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1194\/jlr.S074039_bib51","doi-asserted-by":"crossref","DOI":"10.1097\/MOL.0000000000000423","article-title":"Beyond cascade screening: detection of familial hypercholesterolaemia at childhood immunization and other strategies","author":"Martin","year":"2017","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1194\/jlr.S074039_bib52","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1542\/peds.89.3.495","article-title":"National cholesterol education program (NCEP): highlights of the report of the expert panel on blood cholesterol levels in children and adolescents","volume":"89","year":"1992","journal-title":"Pediatrics."},{"key":"10.1194\/jlr.S074039_bib53","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1542\/peds.84.2.365","article-title":"Family history evaluation as a predictive screen for childhood hypercholesterolemia. Pediatric Practice Research Group","volume":"84","author":"Griffin","year":"1989","journal-title":"Pediatrics."},{"key":"10.1194\/jlr.S074039_bib54","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1542\/peds.2009-2546","article-title":"Universal versus targeted blood cholesterol screening among youth: the CARDIAC project","volume":"126","author":"Ritchie","year":"2010","journal-title":"Pediatrics."},{"issue":"Suppl. 5","key":"10.1194\/jlr.S074039_bib55","first-page":"S213","article-title":"Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report","volume":"128","author":"Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents; National Heart, Lung, and Blood Institute","year":"2011","journal-title":"Pediatrics."},{"key":"10.1194\/jlr.S074039_bib56","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cca.2013.03.027","article-title":"Impact of interpretative commenting on lipid profiles in people at high risk of familial hypercholesterolaemia","volume":"422","author":"Bell","year":"2013","journal-title":"Clin. Chim. Acta."},{"key":"10.1194\/jlr.S074039_bib57","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.atherosclerosis.2014.04.002","article-title":"Detecting familial hypercholesterolaemia in the community: impact of a telephone call from a chemical pathologist to the requesting general practitioner","volume":"234","author":"Bell","year":"2014","journal-title":"Atherosclerosis."},{"key":"10.1194\/jlr.S074039_bib58","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.hlc.2014.07.062","article-title":"Optimising the detection and management of familial hypercholesterolaemia: central role of primary care and its integration with specialist services","volume":"23","author":"Vickery","year":"2014","journal-title":"Heart Lung Circ."},{"key":"10.1194\/jlr.S074039_bib59","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1136\/heartjnl-2015-308824","article-title":"A new electronic screening tool for identifying risk of familial hypercholesterolaemia in general practice","volume":"102","author":"Troeung","year":"2016","journal-title":"Heart."},{"key":"10.1194\/jlr.S074039_bib60","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1161\/01.CIR.0000058166.99182.54","article-title":"Family history and cardiovascular risk in familial hypercholesterolemia: data in more than 1000 children","volume":"107","author":"Wiegman","year":"2003","journal-title":"Circulation."},{"key":"10.1194\/jlr.S074039_bib61","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1515\/CCLM.2008.135","article-title":"Development of sensitive and specific age- and gender-specific low-density lipoprotein cholesterol cutoffs for diagnosis of first-degree relatives with familial hypercholesterolaemia in cascade testing","volume":"46","author":"Starr","year":"2008","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1194\/jlr.S074039_bib62","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1093\/eurheartj\/ehw152","volume":"37","author":"Nordestgaard","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1194\/jlr.S074039_bib63","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1016\/j.jacl.2011.03.453","article-title":"Pediatric aspects of familial hypercholesterolemias: recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia","volume":"5","author":"Daniels","year":"2011","journal-title":"J. Clin. Lipidol."},{"key":"10.1194\/jlr.S074039_bib64","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1093\/eurheartj\/ehu274","article-title":"Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the consensus panel on familial hypercholesterolaemia of the European Atherosclerosis Society","volume":"35","author":"Cuchel","year":"2014","journal-title":"Eur. Heart J."},{"key":"10.1194\/jlr.S074039_bib65","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.atherosclerosis.2016.03.009","article-title":"Phenotype diversity among patients with homozygous familial hypercholesterolemia: a cohort study","volume":"248","author":"Raal","year":"2016","journal-title":"Atherosclerosis."},{"key":"10.1194\/jlr.S074039_bib66","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1161\/CIRCULATIONAHA.116.022335","article-title":"Long-term risk of atherosclerotic cardiovascular disease in US adults with the familial hypercholesterolemia phenotype","volume":"134","author":"Perak","year":"2016","journal-title":"Circulation."},{"key":"10.1194\/jlr.S074039_bib67","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1161\/CIRCULATIONAHA.116.024541","article-title":"Predicting cardiovascular events in familial hypercholesterolemia: the SAFEHEART registry (Spanish Familial Hypercholesterolemia Cohort Study)","volume":"135","author":"P\u00e9rez de Isla","year":"2017","journal-title":"Circulation."},{"key":"10.1194\/jlr.S074039_bib68","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jacl.2017.03.019","article-title":"Polygenic risk score predicts prevalence of cardiovascular disease in patients with familial hypercholesterolemia","volume":"11","author":"Paquette","year":"2017","journal-title":"J. Clin. Lipidol."},{"key":"10.1194\/jlr.S074039_bib69","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1172\/JCI116983","article-title":"Impairment of endothelium-dependent dilation is an early event in children with familial hypercholesterolemia and is related to the lipoprotein(a) level","volume":"93","author":"Sorensen","year":"1994","journal-title":"J. Clin. Invest."},{"key":"10.1194\/jlr.S074039_bib70","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1161\/HYPERTENSIONAHA.109.192639","article-title":"Noninvasive assessment of subclinical atherosclerosis in children and adolescents: recommendations for standard assessment for clinical research: a scientific statement from the American Heart Association","volume":"54","author":"Urbina","year":"2009","journal-title":"Hypertension."},{"key":"10.1194\/jlr.S074039_bib71","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1001\/archinte.166.21.2341","article-title":"Prediction of coronary artery calcium in young adults using the pathobiological determinants of atherosclerosis in youth (PDAY) risk score: the CARDIA study","volume":"166","author":"Gidding","year":"2006","journal-title":"Arch. Intern. Med."},{"key":"10.1194\/jlr.S074039_bib72","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1016\/j.jacc.2012.09.017","article-title":"Effect of long-term exposure to lower low-density lipoprotein cholesterol beginning early in life on the risk of coronary heart disease: a Mendelian randomization analysis","volume":"60","author":"Ference","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1194\/jlr.S074039_bib73","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/ng.784","article-title":"Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease","volume":"43","author":"Schunkert","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1194\/jlr.S074039_bib74","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/ng.2480","article-title":"Large-scale association analysis identifies new risk loci for coronary artery disease","volume":"45","author":"Deloukas","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1194\/jlr.S074039_bib75","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","article-title":"Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins","volume":"366","author":"Baigent","year":"2005","journal-title":"Lancet."},{"key":"10.1194\/jlr.S074039_bib76","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","author":"Baigent","year":"2010","journal-title":"Lancet."},{"key":"10.1194\/jlr.S074039_bib77","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIR.0000000000000510","article-title":"Dietary fats and cardiovascular disease: a presidential advisory from the American Heart Association","volume":"136","author":"Sacks","year":"2017","journal-title":"Circulation."},{"key":"10.1194\/jlr.S074039_bib78","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/j.jacl.2015.04.009","article-title":"Familial hypercholesterolemia in children and adolescents: a clinical perspective","volume":"9","author":"de Ferranti","year":"2015","journal-title":"J. Clin. Lipidol."},{"key":"10.1194\/jlr.S074039_bib79","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1824-7288-40-42","article-title":"Plant sterols-enriched diet decreases small, dense LDL-cholesterol levels in children with hypercholesterolemia: a prospective study","volume":"40","author":"Garoufi","year":"2014","journal-title":"Ital. J. Pediatr."},{"key":"10.1194\/jlr.S074039_bib80","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1093\/ajcn\/76.2.338","article-title":"Plant sterol ester-enriched spread lowers plasma total and LDL cholesterol in children with familial hypercholesterolemia","volume":"76","author":"Amundsen","year":"2002","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1194\/jlr.S074039_bib81","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.jpeds.2005.11.023","article-title":"Plant stanols do not restore endothelial function in pre-pubertal children with familial hypercholesterolemia despite reduction of low-density lipoprotein cholesterol levels","volume":"148","author":"Jakulj","year":"2006","journal-title":"J. Pediatr."},{"key":"10.1194\/jlr.S074039_bib82","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/ajcn\/63.1.96","article-title":"A psyllium-enriched cereal for the treatment of hypercholesterolemia in children: a controlled, double-blind, crossover study","volume":"63","author":"Davidson","year":"1996","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1194\/jlr.S074039_bib83","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.amjcard.2004.12.014","article-title":"Effect of docosahexaenoic acid on lipoprotein subclasses in hyperlipidemic children (the EARLY study)","volume":"95","author":"Engler","year":"2005","journal-title":"Am. J. Cardiol."},{"key":"10.1194\/jlr.S074039_bib84","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1080\/07315724.2002.10719201","article-title":"Effect of a rapeseed oil substituting diet on serum lipids and lipoproteins in children and adolescents with familial hypercholesterolemia","volume":"21","author":"Gulesserian","year":"2002","journal-title":"J. Am. Coll. Nutr."},{"key":"10.1194\/jlr.S074039_bib85","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0022-3476(05)81533-1","article-title":"Effect of soy protein diet versus standard low fat, low cholesterol diet on lipid and lipoprotein levels in children with familial or polygenic hypercholesterolemia","volume":"123","author":"Widhalm","year":"1993","journal-title":"J. Pediatr."},{"key":"10.1194\/jlr.S074039_bib86","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.numecd.2009.10.015","article-title":"The treatment of hypercholesterolemic children: efficacy and safety of a combination of red yeast rice extract and policosanols","volume":"21","author":"Guardamagna","year":"2011","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"10.1194\/jlr.S074039_bib87","first-page":"CD001918","article-title":"Dietary interventions (plant sterols, stanols, omega-3 fatty acids, soy protein and dietary fibers) for familial hypercholesterolaemia","author":"Malhotra","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1194\/jlr.S074039_bib88","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1038\/nm1135","article-title":"Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins","volume":"10","author":"Kong","year":"2004","journal-title":"Nat. Med."},{"key":"10.1194\/jlr.S074039_bib89","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jacl.2013.11.003","article-title":"Nutraceutical approach to moderate cardiometabolic risk: results of a randomized, double-blind and crossover study with Armolipid Plus","volume":"8","author":"Ruscica","year":"2014","journal-title":"J. Clin. Lipidol."},{"key":"10.1194\/jlr.S074039_bib90","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1093\/eurheartj\/ehr158","article-title":"ESC\/EAS guidelines for the management of dyslipidaemias: the task force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)","volume":"32","author":"Reiner","year":"2011","journal-title":"Eur. Heart J."},{"key":"10.1194\/jlr.S074039_bib91","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1016\/S0140-6736(16)31357-5","article-title":"Interpretation of the evidence for the efficacy and safety of statin therapy","volume":"388","author":"Collins","year":"2016","journal-title":"Lancet."},{"key":"10.1194\/jlr.S074039_bib92","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s40272-014-0116-y","article-title":"Long-term statin treatment in children with familial hypercholesterolemia: more insight into tolerability and adherence","volume":"17","author":"Braamskamp","year":"2015","journal-title":"Paediatr. Drugs."},{"key":"10.1194\/jlr.S074039_bib93","first-page":"1285","article-title":"A 10-year experience using combined lipid-lowering pharmacotherapy in children and adolescents","volume":"29","author":"Araujo","year":"2016","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"10.1194\/jlr.S074039_bib94","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.jpeds.2015.02.043","article-title":"Efficacy and safety of ezetimibe monotherapy in children with heterozygous familial or nonfamilial hypercholesterolemia","volume":"166","author":"Kusters","year":"2015","journal-title":"J. Pediatr."},{"key":"10.1194\/jlr.S074039_bib95","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jpeds.2009.08.037","article-title":"Colesevelam hydrochloride: efficacy and safety in pediatric subjects with heterozygous familial hypercholesterolemia","volume":"156","author":"Stein","year":"2010","journal-title":"J. Pediatr."},{"key":"10.1194\/jlr.S074039_bib96","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1093\/eurheartj\/ehw010","article-title":"Initiation of PCSK9 inhibition in patients with heterozygous familial hypercholesterolaemia entering adulthood: a new design for living with a high-risk condition?","volume":"37","author":"Vuorio","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1194\/jlr.S074039_bib97","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1093\/eurheartj\/ehw098","article-title":"Replacing statins with PCSK9-inhibitors and delaying treatment until 18 years of age in patients with familial hypercholesterolaemia is not a good idea","volume":"37","author":"Langslet","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1194\/jlr.S074039_bib98","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/j.1471-0528.2008.02084.x","article-title":"Management of fertility in women with familial hypercholesterolaemia: summary of NICE guidance","volume":"116","author":"Thorogood","year":"2009","journal-title":"BJOG."},{"key":"10.1194\/jlr.S074039_bib99","doi-asserted-by":"crossref","first-page":"h1035","DOI":"10.1136\/bmj.h1035","article-title":"Statins and congenital malformations: cohort study","volume":"350","author":"Bateman","year":"2015","journal-title":"BMJ."},{"key":"10.1194\/jlr.S074039_bib100","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/1471-0528.12066","article-title":"Pregnancy outcome following maternal exposure to statins: a multicentre prospective study","volume":"120","author":"Winterfeld","year":"2013","journal-title":"BJOG."},{"key":"10.1194\/jlr.S074039_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacl.2017.04.114","article-title":"Toward an international consensus-integrating lipoprotein apheresis and new lipid-lowering drugs","author":"Stefanutti","year":"2017","journal-title":"J. Clin. Lipidol."},{"key":"10.1194\/jlr.S074039_bib102","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.beem.2013.10.004","article-title":"Lipoprotein apheresis and new therapies for severe familial hypercholesterolemia in adults and children","volume":"28","author":"Page","year":"2014","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1194\/jlr.S074039_bib103","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S2213-8587(17)30044-X","article-title":"Long-term treatment with evolocumab added to conventional drug therapy, with or without apheresis, in patients with homozygous familial hypercholesterolaemia: an interim subset analysis of the open-label TAUSSIG study","volume":"5","author":"Raal","year":"2017","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1194\/jlr.S074039_bib104","doi-asserted-by":"crossref","first-page":"3588","DOI":"10.1093\/eurheartj\/ehw388","article-title":"Alirocumab in patients with heterozygous familial hypercholesterolaemia undergoing lipoprotein apheresis: the ODYSSEY ESCAPE trial","volume":"37","author":"Moriarty","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1194\/jlr.S074039_bib105","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.jacl.2016.05.006","article-title":"Ten years of lipoprotein apheresis for familial hypercholesterolemia in Malaysia: a creative approach by a cardiologist in a developing country","volume":"10","author":"Khoo","year":"2016","journal-title":"J. Clin. Lipidol."},{"key":"10.1194\/jlr.S074039_bib106","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1080\/13548506.2011.644246","article-title":"Being at risk for cardiovascular disease: perceptions and preventive behavior in people with and without a known genetic predisposition","volume":"17","author":"Claassen","year":"2012","journal-title":"Psychol. Health Med."},{"key":"10.1194\/jlr.S074039_bib107","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s12529-014-9402-x","article-title":"Patients' perceptions and experiences of familial hypercholesterolemia, cascade genetic screening and treatment","volume":"22","author":"Hardcastle","year":"2015","journal-title":"Int. J. Behav. Med."},{"key":"10.1194\/jlr.S074039_bib108","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1136\/adc.2003.045377","article-title":"The adolescent with a chronic condition. Part II: healthcare provision","volume":"89","author":"Michaud","year":"2004","journal-title":"Arch. Dis. Child."},{"key":"10.1194\/jlr.S074039_bib109","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1161\/CIRCOUTCOMES.113.000288","article-title":"Shared decision making: science and action","volume":"7","author":"Ting","year":"2014","journal-title":"Circ. Cardiovasc. Qual. Outcomes."},{"issue":"Suppl. 40","key":"10.1194\/jlr.S074039_bib110","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1177\/014107680109440s02","article-title":"Barriers and good practice in transition from paediatric to adult care","volume":"94","author":"Viner","year":"2001","journal-title":"J. R. Soc. Med."},{"key":"10.1194\/jlr.S074039_bib111","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.atherosclerosis.2015.09.021","article-title":"Familial hypercholesterolaemia: a global call to arms","volume":"243","author":"Vallejo-Vaz","year":"2015","journal-title":"Atherosclerosis."},{"key":"10.1194\/jlr.S074039_bib112","doi-asserted-by":"crossref","first-page":"505","DOI":"10.5551\/jat.34108","article-title":"International developments in the care of familial hypercholesterolemia: where now and where to next?","volume":"23","author":"Pang","year":"2016","journal-title":"J. Atheroscler. Thromb."},{"key":"10.1194\/jlr.S074039_bib113","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.ahj.2013.12.008","article-title":"Rationale and design of the familial hypercholesterolemia foundation Cascade Screening for Awareness and Detection of Familial Hypercholesterolemia registry","volume":"167","author":"O'Brien","year":"2014","journal-title":"Am. Heart J."},{"key":"10.1194\/jlr.S074039_bib114","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0021-9150(98)00200-7","article-title":"Mortality in treated heterozygous familial hypercholesterolaemia: implications for clinical management. Scientific Steering Committee on behalf of the Simon Broome Register Group","volume":"142","year":"1999","journal-title":"Atherosclerosis."},{"key":"10.1194\/jlr.S074039_bib115","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1476-511X-10-94","article-title":"Clinical characteristics and evaluation of LDL-cholesterol treatment of the Spanish Familial Hypercholesterolemia Lon\u00adgitudinal Cohort Study (SAFEHEART)","volume":"10","author":"Mata","year":"2011","journal-title":"Lipids Health Dis."},{"key":"10.1194\/jlr.S074039_bib116","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.lpm.2013.01.053","article-title":"[Diagnostic and treatment of familial hypercholesterolemia (FH) in adult: guidelines from the New French Society of Atherosclerosis (NSFA)]","volume":"42","author":"Farnier","year":"2013","journal-title":"Presse Med."},{"key":"10.1194\/jlr.S074039_bib117","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/1744-1609.12023","article-title":"Role of international registries in enhancing the care of familial hypercholesterolaemia","volume":"11","author":"Hammond","year":"2013","journal-title":"Int. J. Evid.-Based Healthc."},{"key":"10.1194\/jlr.S074039_bib118","doi-asserted-by":"crossref","DOI":"10.5551\/jat.37507","article-title":"Design of the Familial Hypercholesterolaemia Australasia Network Registry: creating opportunities for greater international collaboration","author":"Bellgard","year":"2017","journal-title":"J. Atheroscler. Thromb."},{"key":"10.1194\/jlr.S074039_bib119","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/j.cjca.2014.09.028","article-title":"Canadian Cardiovascular Society position statement on familial hypercholesterolemia","volume":"30","author":"Genest","year":"2014","journal-title":"Can. J. Cardiol."},{"key":"10.1194\/jlr.S074039_bib120","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jacl.2014.11.008","article-title":"Familial hypercholesterolemia mutations in the Middle Eastern and North African region: a need for a national registry","volume":"9","author":"Bamimore","year":"2015","journal-title":"J. Clin. Lipidol."},{"key":"10.1194\/jlr.S074039_bib121","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1161\/CIRCULATIONAHA.110.979450","article-title":"Molecular basis of autosomal dominant hypercholesterolemia: assessment in a large cohort of hypercholesterolemic children","volume":"123","author":"van der Graaf","year":"2011","journal-title":"Circulation."},{"key":"10.1194\/jlr.S074039_bib122","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/archdischild-2015-308570","article-title":"The UK Paediatric Familial Hypercholesterolaemia Register: preliminary data","volume":"102","author":"Ramaswami","year":"2017","journal-title":"Arch. Dis. Child."},{"key":"10.1194\/jlr.S074039_bib123","doi-asserted-by":"crossref","first-page":"232","DOI":"10.5694\/mja16.00070","article-title":"Progress in the care of familial hypercholesterolaemia: 2016","volume":"205","author":"Bell","year":"2016","journal-title":"Med. J. Aust."}],"container-title":["Journal of Lipid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227520339481?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227520339481?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1194\/jlr.S074039","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T23:09:09Z","timestamp":1640041749000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022227520339481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":123,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S0022227520339481"],"URL":"https:\/\/doi.org\/10.1194\/jlr.s074039","relation":{},"ISSN":["0022-2275"],"issn-type":[{"value":"0022-2275","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Knowns and unknowns in the care of pediatric familial hypercholesterolemia","name":"articletitle","label":"Article Title"},{"value":"Journal of Lipid Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1194\/jlr.S074039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}]}}